Parthenolide: from plant shoots to cancer roots.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Drug Discovery Today

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.drudis.2013.05.005PMID 23688583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.

  2013cited by this paper
• Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres

  2013cited by this paper
• NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites.

  2013cited by this paper
• Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.

  2013cited by this paper
• Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide’s anti-leukemic activity

  2013cited by this paper
• Targeting Radioresistant Osteosarcoma Cells With Parthenolide

  2012cited by this paper
• Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model

  2012cited by this paper
• Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis.

  2012cited by this paper
• Combined effects of FLT3 and NF‐κB selective inhibitors on acute myeloid leukemia in vivo

  2012cited by this paper
• Inhibition of Tumor Promotion by Parthenolide: Epigenetic Modulation of p21

  2012cited by this paper
• Cancer stem cell definitions and terminology: the devil is in the details

  2012cited by this paper
• Reactive Oxygen Species in Cancer Stem Cells

  2012cited by this paper
• How close are we to targeting the leukemia stem cell?

  2012cited by this paper
• Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo

  2012cited by this paper
• Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide

  2012cited by this paper
• Epigenetic mechanisms of plant-derived anticancer drugs.

  2012cited by this paper
• Drugs that Kill Cancer Stem-like Cells

  2011cited by this paper
• The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma

  2011cited by this paper
• Feverfew (Tanacetum parthenium L.): A systematic review

  2011cited by this paper
• Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.

  2011cited by this paper
• A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco‐associated cancers, lung and bladder cancer, by targeting NF‐κB and generating reactive oxygen species

  2011cited by this paper
• Parthenolide, a Sesquiterpene Lactone, Expresses Multiple Anti-cancer and Anti-inflammatory Activities

  2011cited by this paper
• Perspectives on sesquiterpene lactones in inflammation and cancer.

  2011cited by this paper
• Melampomagnolide B: a new antileukemic sesquiterpene.

  2011cited by this paper
• Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics.

  2011cited by this paper
• Hearing loss and tinnitus--the hidden healthcare time bomb.

  2010cited by this paper
• Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.

  2010cited by this paper
• Myeloperoxidase Expression as a Potential Determinant of Parthenolide-Induced Apoptosis in Leukemia Bulk and Leukemia Stem Cells

  2010cited by this paper
• [Effect of parthenolide on leukemia K562 cells and its leukemia stem cells].

  2010cited by this paper
• A water‐soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFκB and generating reactive oxygen species

  2010cited by this paper
• Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.

  2010cited by this paper
• Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro

  2010cited by this paper
• What made sesquiterpene lactones reach cancer clinical trials?

  2010cited by this paper
• New agents for the treatment of leukemia: discovery of DMAPT (LC-1)

  2010cited by this paper
• Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).

  2009cited by this paper
• Modulation of Cell Surface Protein Free Thiols: A Potential Novel Mechanism of Action of the Sesquiterpene Lactone Parthenolide

  2009cited by this paper
• Nuclear Factor-κB Inhibition by Parthenolide Potentiates the Efficacy of Taxol in Non–Small Cell Lung Cancer In vitro and In vivo

  2009cited by this paper
• Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives.

  2009cited by this paper
• Effects of the sesquiterpene lactone parthenolide on prostate tumor‐initiating cells: An integrated molecular profiling approach

  2009cited by this paper
• A Novel Combination Therapy With Arsenic Trioxide and Parthenolide Against Pancreatic Cancer Cells

  2009cited by this paper
• Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide

  2009cited by this paper
• Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo

  2009cited by this paper
• Antileukemic activity of aminoparthenolide analogs.

  2008cited by this paper
• Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.

  2008cited by this paper
• Effect of Celecoxib and the Novel Anti-Cancer Agent, Dimethylamino-Parthenolide, in a Developmental Model of Pancreatic Cancer

  2008cited by this paper
• Cancer stem cells: Models, mechanisms and implications for improved treatment

  2008cited by this paper
• A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.

  2008cited by this paper
• Identification of cells initiating human melanomas

  2008cited by this paper
• Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.

  2008cited by this paper
• NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.

  2008cited by this paper
• Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions

  2008cited by this paper
• Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways

  2008cited by this paper
• Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes.

  2008cited by this paper
• NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells

  2008cited by this paper
• Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated.

  2007cited by this paper
• An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

  2007cited by this paper
• Parthenolide, a Natural Inhibitor of Nuclear Factor-κB, Inhibits Lung Colonization of Murine Osteosarcoma Cells

  2007cited by this paper
• Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF‐κB

  2007cited by this paper
• Signaling Pathways in Cancer and Embryonic Stem Cells

  2007cited by this paper
• Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo

  2007cited by this paper
• Epigenetic stem cell signature in cancer

  2007cited by this paper
• Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.

  2007cited by this paper
• Parthenolide inhibits tubulin carboxypeptidase activity.

  2007cited by this paper
• Suppressive effects of dehydroepiandrosterone and the nuclear factor-kappaB inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo.

  2006cited by this paper
• Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

  2006cited by this paper
• Analytical method development and pharmacokinetics studies with parthenolide (NSC 157035) and a water-soluble analog (NSC 734325)

  2005cited by this paper
• The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.

  2005cited by this paper
• Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.

  2005cited by this paper
• Feverfew: weeding out the root of leukaemia

  2005cited by this paper
• Prevention of the Ultraviolet B-Mediated Skin Photoaging by a Nuclear Factor κB Inhibitor, Parthenolide

  2005cited by this paper
• The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer

  2005cited by this paper
• Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.

  2004cited by this paper
• Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.

  2004cited by this paper
• Chapter 63 – Feverfew (Tanacetum parthenium)

  2003cited by this paper
• The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.

  2001cited by this paper
• Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones*

  2001cited by this paper
• The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.

  1999cited by this paper
• The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex

  1999cited by this paper
• Production of parthenolide in organ cultures of feverfew

  1997cited by this paper
• Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF‐κB

  1997cited by this paper
• Feverfew: chemistry and biological activity.

  1995cited by this paper
• Parthenolide content of feverfew (Tanacetum parthenium) assessed by HPLC and 1H-NMR spectroscopy

  1991cited by this paper
• Sesquiterpene lactones and other constituents from Tanacetum parthenium

  1982cited by this paper
• Tumor inhibitory agent from Magnolia grandiflora (Magnoliaceae). I. Parthenolide.

  1973cited by this paper

• Fluorinated terpenoids and their fluorine-containing derivatives

  2026cites this paper
• Parthenolide Alleviates Peritoneal Fibrosis by Blocking Smad2/3 Phosphorylation via Smad Anchor for Receptor Activation

  2026cites this paper
• Parthenolide disrupts mitosis by inhibiting ZNF207/BUGZ-promoted kinetochore-microtubule attachment

  2025cites this paper
• Parthenolide reverses cisplatin-resistant in ovarian cancer: An observational network pharmacology and molecular docking study

  2025cites this paper
• Targeting the NLRP3 inflammasome signalling in acute myeloid leukemia: Mechanisms, therapeutics, and future directions.

  2025cites this paper
• Discovery of novel fluorine-containing parthenolide analogues as potential antitumor agents.

  2025cites this paper
• Asymmetric Catalytic Synthesis of α,β-Unsaturated γ-Lactone and γ-Lactam

  2025cites this paper
• A pathway to next-generation mast cell stabilizers identified through the novel Phytomedical Analytics for Research Optimization at Scale data platform

  2025cites this paper
• Determination of survival associated genetic biomarkers to discover novel therapeutic targets for acute myeloid leukaemia.

  2025cites this paper
• Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide

  2025cites this paper
• Parthenolide Restores Testosterone Biosynthesis After Nanoplastic Exposure by Blocking ROS-Driven NF-κB Nuclear Translocation

  2025cites this paper
• Privileged natural product compound classes for anti-inflammatory drug development.

  2025cites this paper
• Compositional Analysis of Eight Edible Seaweeds and Potential Anti-tumor Mechanisms of the Differential Components Based on UPLC-QE-MS/MS, Network Pharmacology and Molecular docking

  2025cites this paper
• Primary effusion lymphoma: therapeutic strategies targeting viral and cellular mechanisms

  2025cites this paper
• Parthenolide promotes glucagon-like peptide-1 secreting in human Caco-2 cells via regulation of bitter taste receptor-induced of calcium signaling.

  2025cites this paper
• Beyond the pill: incrimination of nuclear factor-kappa B and their targeted phytomedicine for pulmonary fibrosis

  2025cites this paper
• Metabolite distribution, relationships of phytochemical compositions and anticancer compound tracking in organs of Tanacetum parthenium L. as a sustainable pharmaceutical manufacturing plant

  2025cites this paper
• Plant-derived compounds with antineoplastic activity: a literature review

  2025cites this paper
• Synthesis of Novel Spiro-Isoxazolidine Derivatives of 9α-Hydroxyparthenolide

  2025cites this paper
• Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways

  2025cites this paper
• ACT001 alleviates MASLD through gut microbiota–bile acid–FXR axis in mice

  2025cites this paper
• Parthenolide ameliorates diabetic retinopathy by suppressing microglia-induced Müller cell gliosis and inflammation via the NF-κB signalling.

  2025cites this paper
• Design, synthesis and bioactivity evaluation of parthenolide-chalcone hybrids as potential anti-lung cancer agents.

  2025cites this paper
• Parthenolide inhibits Hsp90α ATPase activity and overcomes acquired BRAF-inhibitor resistance in cutaneous melanoma.

  2025cites this paper
• Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy

  2024cites this paper
• Plant sesquiterpene lactones

  2024cites this paper
• RNA modification in normal hematopoiesis and hematologic malignancies

  2024cites this paper
• Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting

  2024cites this paper
• Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species

  2024cites this paper
• Alleviative effects of the parthenolide derivative ACT001 on insulin resistance induced by sodium propionate combined with a high-fat diet and its potential mechanisms.

  2024cites this paper
• ACT001 inhibits primary central nervous system lymphoma tumor growth by enhancing the anti-tumor effect of T cells.

  2024cites this paper
• Computational analysis of ligands from natural products on the cellular targets of combined hepatocellular carcinoma and cholangiocarcinoma

  2024cites this paper
• Structural insight into subunit F of respiratory chain complex I from Xanthomonas oryzae pv. oryzae inhibition by parthenolide.

  2024cites this paper
• Five Himalayan weeds as potential bioresources for bioactive agents: toxic compounds to valuable scaffolds

  2024cites this paper
• Investigating the influence of trichostatin A on gene expression modulation associated with parthenolide biosynthesis and accumulation in Tanacetum parthenium (feverfew)

  2024cites this paper
• Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action

  2024cites this paper
• Sesquiterpenoids in Agarwood: Biosynthesis, Microbial Induction, and Pharmacological Activities.

  2024cites this paper
• Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways

  2024cites this paper
• Differential phytochemical responses of Feverfew to green synthesized calcium nanostructures formed on pectin and Aloe vera extract

  2024cites this paper
• Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes

  2024influential citation
• A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.

  2024cites this paper
• Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment

  2024cites this paper
• Synthesis of scaberol C amino acid ester derivatives with anti-cancer activity

  2024cites this paper
• Persianolide-A, an eudesmanolide-type sesquiterpene lactone from Artemisia kopetdaghensis, induces apoptosis by regulating ERK signaling pathways

  2024cites this paper
• Trends in parthenolide research over the past two decades: A bibliometric analysis

  2023cites this paper
• C-H modification of natural products: a minimalist enabling tactic for drug discovery, API processing and bioconjugation.

  2023cites this paper
• The Secret Lives of Transcription Factors: In Heterochromatin Regulation

  2023cites this paper
• Inhibitory effect of parthenolide on peripheral nerve degeneration

  2023cites this paper
• Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors

  2023cites this paper
• Parthenolide targets NLRP3 to treat inflammasome-related diseases.

  2023cites this paper
• Investigation of targets and anticancer mechanisms of covalently acting natural products by functional proteomics

  2023cites this paper
• Restoration of PM2.5-induced spermatogonia GC-1 cellular damage by parthenolide via suppression of autophagy and inflammation: an in vitro study.

  2023cites this paper
• Biosynthesis of anticancer phytochemical compounds and their chemistry

  2023cites this paper
• Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway

  2023cites this paper
• The effect of natural products on inflammatory cytokines production and secretion

  2023cites this paper
• Bioactivities and the structural modification of Parthenolide: a review

  2023cites this paper
• Engaging Isatins and Amino Acids in Multicomponent One-Pot 1,3-Dipolar Cycloaddition Reactions—Easy Access to Structural Diversity

  2023cites this paper
• Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates peritoneal fibrosis

  2023cites this paper
• Stereoelectronic Effect in the Reaction of α-Methylene Lactones with Tertiary Phosphines and Its Application in Organocatalysis.

  2023cites this paper
• Photocatalytic C-Si Bond Formations Using Pentacoordinate Silylsilicates as Silyl Radical Precursors: Synthetic Tricks Using Old Reagents.

  2023cites this paper
• Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation

  2023cites this paper
• Ameliorative effects of apigenin on a rat model of endometriosis

  2023cites this paper
• Parthenolide As a Therapeutic for Disseminated Canine Neoplasms

  2023cites this paper
• Ubiquitin–proteasome system as a target for anticancer treatment—an update

  2023cites this paper
• Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis

  2023cites this paper
• Fractions of Hoslundia opposita Vahl and hoslundin induced apoptosis in human cancer cells via mitochondrial-dependent reactive oxygen species (ROS) generation.

  2022cites this paper
• The anti-tumor effect of a novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma

  2022cites this paper
• Computational identification of natural senotherapeutic compounds that mimic dasatinib based on gene expression data

  2022cites this paper
• Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide

  2022influential citation
• Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents.

  2022cites this paper
• Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology.

  2022cites this paper
• Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment

  2022cites this paper
• DDDT_A_355059 1255..1272

  2022cites this paper
• Review: NF-kB activation in canine cancer

  2022cites this paper
• A dual-responsive "Yin-Yang" photothermal delivery system to accelerate Parthenolide anti-tumor efficacy.

  2022cites this paper
• The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma

  2022cites this paper
• Anti-Inflammatory and Immunoregulatory Action of Sesquiterpene Lactones

  2022cites this paper
• Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties

  2022cites this paper
• Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review

  2022cites this paper
• Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer.

  2022cites this paper
• Schild analysis of the interaction between parthenolide and cocaine suggests an allosteric relationship for their effects on planarian motility

  2022cites this paper
• The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy

  2022cites this paper
• PD-L1 negatively regulates antifungal immunity by inhibiting neutrophil release from bone marrow

  2022cites this paper
• Mining and characterization of oxidative stress-related binding proteins of parthenolide in Xanthomonas oryzae pv. oryzae.

  2022cites this paper
• Discovery of α-methylene-γ-lactone-δ-epoxy derivatives with anti-cancer activity: synthesis, SAR study, and biological activity

  2022cites this paper
• NF-κB: A Druggable Target in Acute Myeloid Leukemia

  2022cites this paper
• New 11-Methoxymethylgermacranolides from the Whole Plant of Carpesium divaricatum

  2022cites this paper
• Phenylpropanoids from Tanacetum baltistanicum with Nematocidal and Insecticidal Activities

  2022cites this paper
• Parthenolide promotes expansion of Nestin+ progenitor cells via Shh modulation and contributes to post-injury cerebellar replenishment

  2022cites this paper
• Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis

  2022cites this paper
• Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment

  2022cites this paper
• Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention

  2022cites this paper
• Parthenolide modulates cerebral ischemia-induced microglial polarization and alleviates neuroinflammatory injury via the RhoA/ROCK pathway.

  2022cites this paper
• Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma

  2021cites this paper
• Tripleurospermum disciforme (C.A.Mey.) Sch.Bip., Tanacetum parthenium (L.) Sch.Bip, and Achillea biebersteinii Afan.: efficiency, chemical profile, and biological properties of essential oil

  2021cites this paper
• CYTOTOXIC EFFECT OF CHLOROFORM EXTRACTS FROM TANACETUM VULGARE, T. MACROPHYLLUM AND T. CORYMBOSUM ON HELA, A375 AND V79 CELL LINES

  2021cites this paper
• Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs

  2021cites this paper
• Product Export in Cyanobacteria

  2021cites this paper
• Parthenolide, bioactive compound of Chrysanthemum parthenium L., ameliorates fibrogenesis and inflammation in hepatic fibrosis via regulating the crosstalk of TLR4 and STAT3 signaling pathway

  2021cites this paper
• Terpenoids’ anti-cancer effects: focus on autophagy

  2021cites this paper